Newsletter | June 1, 2026

06.01.26 -- Target Product Profile: The Drug Delivery Cross-Functional Glue

FEATURED EDITORIAL

Target Product Profile: The Drug Delivery Cross-Functional Glue

In this article, Chief Editor Tom von Gunden consults industry veterans with experience in various formulation or delivery roles at GSK and Merck. They identify the Target Product Profile (TPP) as the core concept guiding collaboration across departments during product development. 

Reformulating From IV To At-Home Injection

For Soligenix, reformulation was not a detour but a necessary step toward optimizing a therapy for real-world use. Discover how the team reformulated its drug delivery from in-clinic to at-home administration.

INDUSTRY INSIGHTS

How Dermal Delivery Platforms Are Transforming Tomorrows For Patients

Skin delivery platforms expand therapies by boosting convenience, stability, and adherence. Integrated formulation, device, and manufacturing development is key to confidently scale.

Drug Delivery, Repackaged

Pharmaceutical packaging must evolve alongside drug development to ensure stability and regulatory adherence, utilizing innovative designs to improve therapeutic outcomes and patient accessibility.

Transitioning To USP <382> For Elastomeric Components Of Injectables

A new regulatory chapter requires holistic, real‑world testing of injectable systems, mandating full‑system validation with actual drug products and prioritizing patient‑centric performance and safety.

SOLUTIONS

Pharma Services Fill, Finish & Drug Delivery CDMO

Lipids CDMO Services: Custom Excipients Tailored To Your Needs

From Discovery To Impact: New Approach Methodologies